Monday, October 3, 2022


Biotechnology News Magazine

Carissa Rollins New Chief Information Officer at Illumina

Latest Posts

City of Hope to Accelerate Immunotherapy Research & Treatment Innovation with $15 Mil Gift from Ted Schwartz Family

Ted Schwartz, who is now cancer free, achieved complete remission at City of Hope in 2020 with the center's leading CAR T cell therapy after a 16-year battle with lymphoma, provided the gift to City of Hope to advance treatment options that offer better outcomes and quality of life for people living with cancer.

Neurocrine Biosciences Appoints Dr Ingrid Delaet as Chief Regulatory Officer

Prior to joining Neurocrine Biosciences, Dr Ingrid Delaet served as Senior Vice President, Regulatory Affairs at Intercept Pharmaceuticals, which she joined in 2016.

Astrea Bioseparations Introduces Nereus LentiHERO, a Fit-for-purpose Solution for Lentiviral Vector Purification

“We believe that AstreAdept will be a game-changer,” explained Astrea Bioseparations’ CEO Terry Pizzie. “Our approach was to rapidly develop and incorporate this material into the Nereus LentiHERO, a simple, fit-for-purpose device that radically transforms how lentivirus can be purified [in terms of speed, recovery, and efficiency].

At Pack Expo, Schreiner MediPharm to Debut Functional Labels Designed from More Sustainable Materials

Schreiner MediPharm advises he new label concepts are based on existing items in Schreiner MediPharm’s roster of functional labeling solutions.

Carissa Rollins will join the company as Chief Information Officer on March 14, 2022.

Carissa Rollins brings over 30 years of business technology transformation and digital and consumerization strategy experience. Rollins will report to Chief Executive Officer, Francis deSouza.

Most recently, Rollins was the Chief Information Officer at UnitedHealthcare. She was responsible for the strategy, roadmap, and technology investments supporting the commercial, Medicare and retirement, and government programs technology business portfolios. Before UnitedHealthcare, Rollins held executive and senior leadership positions at Gander Mountain, Kohl’s Corporation, Manpower Global, and Miller-Coors.

“We are delighted to have Carissa join the leadership team at Illumina,” said Francis deSouza, Illumina’s Chief Executive Officer. “Carissa has an excellent track record of leveraging IT innovation at scale to deliver great customer and employee experiences. We’re looking forward to working together to accelerate toward a future of personalized medicine for patients around the world.”

“I look forward to joining the Illumina team and building upon the high-performance teams, ensuring that key stakeholders have a continuously improved experience with IT services and support,” shares Rollins. “For me, by focusing on our talent, the technology innovation will continue to create space to unlock the power of the genome.”

Rollins has served on the Board of Directors for the YWCA, Minneapolis, and is currently the Board Chair. She also serves on the Grand Canyon Conservancy board and the T-Mobile advisory board. Rollins holds a B.S. in Management Information Systems and an MBA from Marquette University.

Latest Posts

Learn More




Our Sister Publication

Medical Device News Magazine